1767.55 +17.11 (+0.97%) Buy

SHRIRAMCIT continues to mint money for it's investors

13 min read

SHRIRAM CITYUNI FIN.LTD. ranked among the best performers today. It delivered +0.97% to close at 1767.55. During the last week it delivered +2.06% and saw a maximum drawdown of -1.29% before bouncing back.

[Themes containing SHRIRAMCIT]

Buy-and-Hold investors in SHRIRAMCIT experienced a maximum drawdown of -7.22% over the last three months. It delivered +15.78% during this strong bullish trending period. There were both Long and Short signals during this period, while the long signals were significantly more profitable than the short signals. The net profit from Long signals was +7.82%.


SHRIRAMCIT has been outperforming the NIFTY-50 index in recent time. It showed significant underperformance (compared to the NIFTY-50 index) from 1 Nov, 2016 to 17 Dec, 2018. Over the last 3 years and 1 month, SHRIRAMCIT underperformed the NIFTY-50 index on 51% days.

During the last three months SHRIRAMCIT was mostly profitable and delivered on average +0.25% per day. It's best return during this period (of +4.36%) was on Wednesday, 24 Oct, 2018. While it's worst loss in the same period (of -4.99%) was on Thursday, 25 Oct, 2018. The longest stort-term trend during this period was 7 profitable days, which started on 10 Jan, 2019 and went on till 18 Jan, 2019. This bullish trend returned +11.61% to investors.

The last 12 months saw SHRIRAMCIT's investors making profits in 6 months and incurring losses in 6 months. During the last year, SHRIRAMCIT delivered profits in more months than NIFTY-50 index. SHRIRAMCIT was also a more risky investment than NIFTY-50 index as it's worst month in the last year, Sep 2018, returned -17.56% compared to -6.42% returned by NIFTY-50 index in Sep 2018. SHRIRAMCIT had a longer winning streak of profitable months than NIFTY-50 index. It went up in 3 straight months (from Feb 2018 to Apr 2018) during which period it delivered +15.56%. It is interesting to note that both SHRIRAMCIT and NIFTY-50 index significantly outperform during months when quarterly/annual results are announced.

A simple fact that is ard to learn is that the time to save money is when you have some.
-- Joe Moore

SHRIRAMCIT is currently seeing overall increase in volatility. In comparison, the NIFTY-50 index is seeing decrease in volatility. During the last three months, there was a significant fall in SHRIRAMCIT's volatility from 23 Oct, 2018 to 4 Jan, 2019. While there was a significant fall in the NIFTY-50 index's volatility from 31 Oct, 2018 to 5 Dec, 2018.

Advanced/professional short-term investors should note that SHRIRAMCIT has positive skewness in it's return distribution. This indicates that investors can expect SHRIRAMCIT to make attempts to recover from drawdowns quickly. Which makes SHRIRAMCIT a good candidate for momentum based trading on short-term bullish trends or counter-trends.

SHRIRAMCIT has more chance of extreme outcomes than the NIFTY-50 index. Therefore, SHRIRAMCIT must receive a lower allocation than NIFTY-50 in your portfolio. NIFTY-50 index usually has shorter drawdown period than SHRIRAMCIT.

On a general note (since you are interested in SHRIRAMCIT), two instruments that deserve special mention are ~CHEMICALS and NIFTY-GS-15YRPLUS. They have significantly outperformed the overall market.

Want to improve your Portfolio's performance?

Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
If you liked what you read here ...

... we have a small favour to ask. Help us bring the power of algorithmic trading strategies to individual investors.

All content in this article was automatically generated by algorithms. This ensures that there are no human biases in the analysis provided. This approach to investing is not new and has been around for more than three decades. Yet, it has been available to only the most affluent or elite investors leaving individual investors to trade on emotions (such as fear and greed), intuition and poor analysis from third-parties. We want to change this.

We want to empower investors with all the tools and analysis required by them to make a rational investment decision.

If you found Spotalpha useful, consider making a contribution. For as little as $5 you can support our efforts and it takes less than a minute. Thank you. Contribute
Share with friends   WhatsApp   Facebook   Twitter